Listed

John Wiley & Sons, Inc.: Form 10-Q for the period ended Jan 31, 2023

Filed with the SEC on Mar 10, 2023 and accepted by EDGAR at Mar 10, 2023, 13:03 ET.

Share

Management's discussion and analysis

As filed, 64,966 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The information in our Management’s Discussion and Analysis of Financial Condition and Results of Operations (MD&A) should be read together with our Condensed Consolidated Financial Statements and related notes set forth in Item 1 of Part I of this Quarterly Report on Form 10-Q, our MD&A set forth in Item 7 of Part II of our 2022 Form 10-K and our Consolidated Financial Statements and related notes set forth in Item 8 of Part II of our 2022 Form 10-K. See Part II, Item 1A, “Risk Factors,” below and “Cautionary Notice Regarding Forward-Looking Statements “Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995,” above, and the information referenced therein, for a description of risks that we face and important factors that we believe could cause actual results to differ materially from those in our forward-looking statements. All amounts and percentages are approximate due to rounding and all dollars are in thousands, except per share amounts or where otherwise noted. When we cross-reference to a “Note,” we are referring to our “Notes to Unaudited Condensed Consolidated Financial Statements,” unless the context indicates otherwise.

OVERVIEW

Wiley is a global leader in scientific research and career-connected education, unlocking human potential by enabling discovery, powering education, and shaping workforces. For over 200 years, Wiley has fueled the world’s knowledge ecosystem. Today, our high-impact content, platforms, and services help researchers, learners, institutions, and corporations achieve their goals in an ever-changing world. Wiley is a predominantly digital company with approximately 84% of revenue generated by digital products and tech-enabled services, and 56% of revenue is recurring, which includes revenue that is contractually obligated or set to recur with a high degree of certainty, for the nine months ended January 31, 2023.

We have reorganized our Education lines of business into two new customer-centric segments. The Academic segment addresses the university customer group and includes Academic Publishing and University Services. The Talent segment addresses the corporate customer group and will be focused on delivering training, sourcing, and upskilling solutions. Prior period segment results have been revised to the new segment presentation. There were no changes to our consolidated financial results. Our new segment reporting structure consists of three reportable segments, as well as a Corporate expense category (no change), which includes certain costs that are not allocated to the reportable segments:

  • Research, includes Research Publishing and Research Solutions, and no changes were made as a result of this realignment;
  • Academic, includes the Academic Publishing and University Services lines. Academic Publishing is the combination of the former Education Publishing line and professional publishing offerings;
  • Talent, is the combination of the former Talent Development line, and our corporate training and corporate learning offerings.

Through the Research segment, we provide peer-reviewed STM publishing, content platforms, and related services to academic, corporate, and government customers, academic societies, and individual researchers. The Academic segment provides scientific, professional, and education print and digital books, digital courseware, and test preparation services, as well as engages in the comprehensive management of online degree programs for universities. The Talent segment services include sourcing, training, and preparing aspiring students and professionals to meet the skill needs of today’s technology careers, and placing them with large companies and government agencies. As well as corporate training and corporate learning offerings.

Wiley’s business strategies are tightly aligned with accelerating growth trends, including open research, career-connected education, and talent development. Research strategies include driving publishing output to meet the global demand for peer-reviewed research and expanding platform and service offerings for corporations and societies. Education strategies include expanding online degree programs and driving online enrollment for university partners, scaling digital content and courseware, and expanding IT talent placement and reskilling programs for corporate partners.

RESULTS OF OPERATIONS – THREE MONTHS ENDED JANUARY 31, 2023

THIRD QUARTER SUMMARY:

  • US GAAP Results: Consolidated Revenue of $491.4 million (-5%, compared with the prior year), Operating Loss of $(67.1) million (compared with the prior year Operating Income of $46.0 million), and Diluted Loss per Share of $(1.29) (compared with the prior year Diluted Earnings per Share of $0.63). Losses primarily due to non-cash goodwill impairment in Education Services/University Services and restructuring charges.
  • Adjusted Results (at constant currency compared with the prior year): Consolidated Revenue of $491.4 million (-2%, compared with the prior year), Adjusted EBITDA of $97.7 million (-3%, compared with the prior year), and Adjusted EPS of $0.85 (-9%, compared with the prior year).
  • Fiscal 2023 Outlook: Reduced to reflect increased Academic headwinds, and a publishing pause in a Hindawi special issues program.
  • As a result of significant currency fluctuations, Wiley noted that Adjusted EBITDA in Research was being adversely impacted by Research royalty expenses denominated in British pounds but derived from US dollar revenues in our UK subsidiary. We have normalized for this foreign currency impact, resulting in a constant currency Adjusted EBITDA benefit of $2 million for the three months ended January 31, 2023 and an $8 million benefit for the nine months ended January 31, 2023. We have also amended our first and second quarters of fiscal year 2023 Adjusted EBITDA (+$3 million each quarter, respectively) for Research and Wiley overall to reflect the benefit for those periods. In the prior fiscal year, this impact was not significant. The Company believes this change will more adequately reflect Wiley’s true operating performance.

CONSOLIDATED RESULTS OF OPERATIONS

Revenue:

Revenue for the three months ended January 31, 2023, decreased $24.5 million, or 5%, as compared with the prior year. On a constant currency basis, revenue decreased 2% as compared with prior year including contributions from acquisitions. Excluding the contributions from acquisitions, organic revenue decreased 3% on a constant currency basis.

See the “Segment Operating Results” below for additional details on each segment’s revenue and Adjusted EBITDA performance.

Cost of Sales:

Cost of sales for the three months ended January 31, 2023, increased $1.1 million, or 1%, as compared with the prior year. On a constant currency basis, cost of sales increased 3% compared with the prior year. This was primarily due to higher employee costs to support the growth in placements in the Talent segment, partially offset by lower royalty costs.

Operating and Administrative Expenses:

Operating and administrative expenses for the three months ended January 31, 2023, decreased $19.7 million, or 7%, as compared with the prior year. On a constant currency basis, operating and administrative expenses decreased 4% as compared with the prior year primarily reflecting lower annual incentive compensation for fiscal year 2023, partially offset by a $3.7 million charge related to the settlement of a litigation matter related to consideration for a previous acquisition in the three months ended January 31, 2023.

Impairment of Goodwill:

We recorded an impairment of goodwill for the three months ended January 31, 2023 of $99.8 million. This charge is reflected in the Impairment of goodwill in the Unaudited Condensed Consolidated Statements of Net (Loss) Income.

In accordance with applicable accounting standards, we were required to test goodwill for impairment immediately before and after our segment realignment. Prior to the realignment, we concluded that the fair value of the Education Services reporting unit was below its carrying value, which resulted in a pretax non-cash goodwill impairment of $31.0 million. Education Services was adversely impacted by market conditions and headwinds for online degree programs. This has led to a decline in projected student enrollments from existing partners, pricing pressures and revenue share concessions, and a decline in new partner additions over both the short-term and long-term, which adversely impacted forecasted revenue growth and operating cash flows. This was partially offset by projected growth in talent placements, partially due to expansion into new regions and the addition of new corporate clients, which are forecasted to have a positive impact on revenue growth and operating cash flows.

After the realignment, we concluded that the fair value of the University Services reporting unit within the Academic segment was below its carrying value, which resulted in an additional pretax non-cash goodwill impairment of $68.8 million. University Services was adversely impacted by market conditions and headwinds for online degree programs, which lead to a decline in projected enrollments from existing partners, pricing pressures and revenue share concessions, and a decline in new partner additions over both the short-term and long-term which adversely impacted forecasted revenue growth and operating cash flows.

See Note 12, “Goodwill and Intangible Assets” for more details on these charges.

Restructuring and Related Charges (Credits):

Fiscal Year 2023 Restructuring Program

In May 2022, the Company initiated a global program to restructure and align our cost base with current and anticipated future market conditions. This program includes severance related charges for the elimination of certain position, the exit of certain leased office space which began in the first quarter of fiscal year 2023 and the reduction of our occupancy at other facilities. We are reducing our real estate square footage occupancy by approximately 22%. We anticipate $30 million in savings from actions starting in fiscal year 2023.

In the three months ended January 31, 2023, due to the political instability and military actions between Russia and Ukraine, we made the decision to close our operations in Russia, which primarily consists of technology development resources. We expect to be substantially completed by April 30, 2023 except for the liquidation of the operations in our fiscal year 2024.

For the three months ended January 31, 2023, we recorded pretax restructuring charges of $8.9 million related to this program, of which $7.5 million related to the closure of our operations in Russia as described above. This restructuring charge primarily reflects the following charges:

  • Severance charges of $7.0 million for the elimination of certain positions;
  • Acceleration of depreciation and amortization of property and equipment of $0.2 million;
  • Consulting, relocation and other costs of $1.0 million; and
  • Ongoing facility-related costs with previously vacated properties that resulted in additional restructuring charges of $0.7 million.

These actions are anticipated to yield annualized cost savings estimated to be approximately $60 million. We anticipate ongoing facility-related costs associated with certain properties to result in additional restructuring charges in future periods.

These charges are reflected in Restructuring and related charges (credits) on our Unaudited Condensed Consolidated Statements of Net (Loss) Income. See Note 9, “Restructuring and Related Charges (Credits)” for more details on these charges.

Business Optimization Program

For the three months ended January 31, 2023 and 2022, we recorded pretax restructuring credits of $0.1 million and charges of $0.4 million, respectively, related to this program. These charges and credits are reflected in Restructuring and related charges (credits) on our Unaudited Condensed Consolidated Statements of Net (Loss) Income. See Note 9, “Restructuring and Related Charges (Credits)” for more details on these charges and credits.

For the impact of our restructuring programs on diluted (loss) earnings per share, see the section below, “Diluted (Loss) Earnings per Share (EPS).”

Amortization of Intangible Assets:

Amortization of intangible assets was $20.0 million for the three months ended January 31, 2023, a decrease of $1.1 million, or 5%, as compared with the prior year. On a constant currency basis, amortization of intangible assets decreased 3% as compared with the prior year primarily due to the completion of amortization of certain acquired intangible assets, partially offset by the amortization of intangible assets related to the acquisitions completed in fiscal year 2022 and 2023. See Note 3, “Acquisitions” for more details on these acquisitions.

Operating (Loss) Income, Adjusted Operating Income (OI) and Adjusted EBITDA:

Operating loss was $(67.1) million for the three months ended January 31, 2023, compared with prior year operating income of $46.0 million. The decrease was primarily due to the impairment of goodwill in the three months ended January 31, 2023 and, to a lesser extent, the decrease in revenue, the increase in restructuring charges and, higher cost of sales, partially offset by a decrease in operating and administrative expenses as described above.

Adjusted OI and Adjusted EBITDA on a constant currency basis and excluding restructuring charges, impairment of goodwill and legal settlement decreased 6% and 3%, respectively, as compared with the prior year. The decrease in Adjusted OI and Adjusted EBITDA was primarily due to lower revenues and, to a lesser extent, higher cost of sales, partially offset by a decrease in operating and administrative expenses as described above.

Adjusted Operating Income (OI)

Below is a reconciliation of our consolidated US GAAP Operating (Loss) Income to Non-GAAP Adjusted OI:

Three Months Ended January 31, 2023 2022
US GAAP Operating (Loss) Income $(67,056) $45,989
Adjustments:
Restructuring and related charges 8,807 448
Impairment of goodwill 99,800 —
Legal settlement (1) 3,671 —
Non-GAAP Adjusted OI $45,222 $46,437

(1) In the three months ended January 31, 2023, we settled a litigation matter related to consideration for a previous acquisition for $3.7 million.

Adjusted EBITDA

Below is a reconciliation of our consolidated US GAAP Net (Loss) Income to Non-GAAP EBITDA and Adjusted EBITDA:

Three Months Ended January 31, 2023 2022
Net (Loss) Income $(71,469) $35,366
Interest expense 11,521 5,103
(Benefit) provision for income taxes (5,982) 7,853
Depreciation and amortization 52,442 53,363
Non-GAAP EBITDA (13,488) 101,685
Impairment of goodwill 99,800 —
Legal settlement 3,671 —
Restructuring and related charges 8,807 448
Foreign exchange transaction (gains) losses (421) 488
Other income, net (705) (2,821)
Non-GAAP Adjusted EBITDA $97,664 $99,800

Interest Expense:

Interest expense for the three months ended January 31, 2023, was $11.5 million compared with the prior year of $5.1 million. This increase was primarily due to a higher weighted average effective interest rate.

Foreign Exchange Transaction Gains (Losses):

Foreign exchange transaction gains of $0.4 million for the three months ended January 31, 2023 were primarily due to gains on our foreign currency denominated intercompany accounts receivable and payables balances, partially offset by losses on our third party accounts receivable and payable balances due to the impact of the change in average foreign exchange rates as compared to the US dollar.

Foreign exchange transaction losses of $(0.5) million for the three months ended January 31, 2022 were primarily due to losses on our foreign currency denominated intercompany and, to a lesser extent, third party accounts receivable and payable balances due to the impact of the change in average foreign exchange rates as compared to the US dollar.

(Benefit) Provision for Income Taxes:

Below is a reconciliation of our US GAAP (Loss) Income Before Taxes to Non-GAAP Adjusted Income Before Taxes:

Three Months Ended January 31, 2023 2022
US GAAP (Loss) Income Before Taxes $(77,451) $43,219
Pretax Impact of Adjustments:
Impairment of goodwill 99,800 —
Legal settlement 3,671 —
Restructuring and related charges 8,807 448
Foreign exchange (gains) losses on intercompany transactions (2,414) 722
Amortization of acquired intangible assets 21,042 22,189
Non-GAAP Adjusted Income Before Taxes $53,455 $66,578

42

Below is a reconciliation of our US GAAP Income Tax (Benefit) Provision to Non-GAAP Adjusted Income Tax Provision, including our US GAAP Effective Tax Rate and our Non-GAAP Adjusted Effective Tax Rate:

Three Months Ended January 31, 2023 2022
US GAAP Income Tax (Benefit) Provision $(5,982) $7,853
Income Tax Impact of Adjustments (1):
Impairment of goodwill 4,857 —
Legal settlement 716 —
Restructuring and related charges 2,221 114
Foreign exchange (gains) losses on intercompany transactions (596) 239
Amortization of acquired intangible assets 4,591 4,834
Non-GAAP Adjusted Income Tax Provision $5,807 $13,040
US GAAP Effective Tax Rate 7.7% 18.2%
Non-GAAP Adjusted Effective Tax Rate 10.9% 19.6%

(1) For the three months ended January 31, 2023, the tax impact was $4.0 million from current taxes and $7.8 million from deferred taxes. For the three months ended January 31, 2022, substantially all of the tax impact was from deferred taxes.

Our effective tax rate fluctuates based on, among other factors, where income is earned and the level of income relative to tax attributes. The US GAAP effective tax rate for the three months ended January 31, 2023, was 7.7% compared to 18.2% for the three months ended January 31, 2022. The US GAAP effective tax rate for the three months ended January 31, 2023, was lower than the US GAAP effective tax rate for the three months ended January 31, 2022, after taking into account certain discrete items realized related to the filing of the consolidated US federal income tax return for the year ended April 30, 2022, the tax impact on the impairment of goodwill, as well as the geographic mix of earnings, the impact of US state taxes, and a discrete item relating to restricted stock compensation.

Excluding the tax impact of the impairment of goodwill, restructuring and other adjustments noted in the table above, the Non-GAAP adjusted effective tax rate was 10.9% for the three months ended January 31, 2023, compared to 19.6% for the three months ended January 31, 2022. The reduction in the Non-GAAP adjusted effective tax rate for the three months ended January 31, 2023, compared with the prior year ended January 31, 2022, was primarily due to the same factors described above.

Diluted (Loss) Earnings per Share (EPS):

EPS for the three months ended January 31, 2023 was a loss of $(1.29) per share compared with earnings of $0.63 per share for the three months ended January 31, 2022. This decrease was due to an operating loss in the three months ended January 31, 2023, partially offset by an income tax benefit in the three months ended January 31, 2023.

Below is a reconciliation of our US GAAP (Loss) Earnings Per Share to Non-GAAP Adjusted EPS. The amount of the pretax, and the related income tax impact for the adjustments included in the table below, are presented in the section above, “(Benefit) Provision for Income Taxes”.

Three Months Ended January 31, 2023 2022
US GAAP (Loss) Earnings Per Share $(1.29) $0.63
Adjustments:
Impairment of goodwill 1.69 —
Legal settlement 0.05 —
Restructuring and related charges 0.12 0.01
Foreign exchange (gains) losses on intercompany transactions (0.03) 0.01
Amortization of acquired intangible assets 0.29 0.30
EPS impact of using weighted-average dilutive shares for adjusted EPS calculation (1) 0.02 —
Non-GAAP Adjusted EPS $0.85 $0.95

(1) Represents the impact of using diluted weighted-average number of common shares outstanding (56.1 million shares for the three months ended January 31, 2023) included in the Non-GAAP Adjusted EPS calculation in order to apply the dilutive impact on adjusted net income due to the effect of unvested restricted stock units and other stock awards. This impact occurs when a US GAAP net loss is reported and the effect of using dilutive shares is antidilutive.

On a constant currency basis, Adjusted EPS decreased 9% primarily due to higher interest expense and, to a lesser extent, a decrease in Adjusted Operating Income and lower pension credits, partially offset by lower income tax expense.

SEGMENT OPERATING RESULTS

RESEARCH Revenue: Three Months Ended January 31, 2023 2022 % Change Favorable (Unfavorable) Constant Currency % Change Favorable (Unfavorable)
Research Publishing (1) $213,720 $224,553 (5)% (3)%
Research Solutions (1) 39,880 38,788 3% 6%
Total Research Revenue 253,600 263,341 (4)% (1)%
Cost of Sales 70,806 72,037 2% —%
Operating Expenses 114,045 117,160 3% (2)%
Amortization of Intangible Assets 11,572 11,979 3% —%
Restructuring Charges (see Note 9) 317 — # #
Contribution to Profit 56,860 62,165 (9)% (10)%
Restructuring Charges (see Note 9) 317 — # #
Adjusted Contribution to Profit 57,177 62,165 (8)% (9)%
Depreciation and amortization 23,123 23,914 3% 1%
Adjusted EBITDA $80,300 $86,079 (7)% (7)%
Adjusted EBITDA Margin 31.7% 32.7%

# Not meaningful

(1) As previously announced in May 2022, our revenue by product type previously referred to as Research Platforms was changed to Research Solutions. Research Solutions includes infrastructure and publishing services that help societies and corporations thrive in a complex knowledge ecosystem. In addition to Platforms (Atypon), certain product offerings such as corporate sales which included the recent acquisitions of Madgex Holdings Limited (Madgex), and Bio-Rad Laboratories Inc.’s Informatics products (Informatics) that were previously included in Research Publishing moved to Research Solutions to align with our strategic focus. Research Solutions also includes product offerings related to certain recent acquisitions such as J&J, and EJP. Prior period results have been revised to the new presentation. There were no changes to the total Research segment or our consolidated financial results. The revenue reclassified was $24.3 million for the three months ended January 31, 2022, $93.3 million for the year ended April 30, 2022, and $80.3 million for the year ended April 30, 2021.

Revenue:

Research revenue for the three months ended January 31, 2023 decreased $9.7 million, or 4%, as compared with the prior year on a reported basis. On a constant currency basis, revenue decreased 1% as compared with the prior year. Excluding revenue from acquisitions, organic revenue decreased 2% on a constant currency basis primarily due to a pause in the Hindawi special issues publishing program. The program was suspended temporarily due to the presence in certain special issues of compromised articles. As a result, Hindawi revenue for the three months ended January 31, 2023 decreased $9 million on a constant currency basis as compared with the prior year, offsetting growth in other open access publishing programs. We have retracted hundreds of articles and the investigation is ongoing. We expect some impact on Hindawi submissions and publications in fiscal year 2024 due to the article backlog that has accumulated and the potential impact on Hindawi journal brands. Excluding Hindawi, Wiley’s Research revenue for the three months ended January 31, 2023 on a constant currency basis increased 2% as compared with the prior year. Open access article output decreased approximately 25% for the three months ended January 31, 2023, as compared with the prior year. Excluding Hindawi, open access article output growth was approximately 17% for the three months ended January 31, 2023.

Adjusted EBITDA:

On a constant currency basis, Adjusted EBITDA decreased 7% as compared with the prior year. This decrease was primarily due to revenue performance and, to a lesser extent, technology investment.

ACADEMIC: Revenue: Three Months Ended January 31, 2023 2022 % Change Favorable (Unfavorable) Constant Currency % Change Favorable (Unfavorable)
Academic Publishing $128,564 $143,583 (10)% (8)%
University Services 48,951 55,435 (12)% (11)%
Total Academic Revenue 177,515 199,018 (11)% (9)%
Cost of Sales 72,920 76,995 5% 4%
Operating Expenses 78,424 83,946 7% 4%
Impairment of Goodwill (see Note 12) 99,800 — # #
Amortization of Intangible Assets 5,183 6,105 15% 15%
Restructuring Charges (see Note 9) 1,851 261 # #
Contribution to Profit (80,663) 31,711 # #
Restructuring Charges (see Note 9) 1,851 261 # #
Impairment of Goodwill (see Note 12) 99,800 — # #
Adjusted Contribution to Profit 20,988 31,972 (34)% (34)%
Depreciation and amortization 19,922 19,693 (1)% (2)%
Adjusted EBITDA $40,910 $51,665 (21)% (20)%
Adjusted EBITDA Margin 23.0% 26.0%

# Not meaningful

Revenue:

Academic revenue decreased $21.5 million, or 11%, as compared with the prior year on a reported basis. On a constant currency basis, revenue decreased 9% as compared with the prior year. Excluding revenue from acquisitions, organic revenue decreased 10% on a constant currency basis. This was primarily due to a decrease in Academic Publishing due to a decline in print and digital, partially offset by growth in digital courseware. University Services revenue decreased primarily due to continued online enrollment challenges, and lower fee for service revenue. For the three months ended January 31, 2023, University Services experienced a 4% decline in online enrollment.

Adjusted EBITDA:

On a constant currency basis, Adjusted EBITDA decreased 20% as compared with the prior year. This decrease was primarily due to the revenue performance.

University Services Partners and Programs:

As of January 31, 2023, Wiley had 66 university partners under contract, compared to 64 as of January 31, 2022 within University Services.

INDEX

TALENT: Three Months Ended January 31, 2023 2022 % Change Favorable (Unfavorable) Constant Currency % Change Favorable (Unfavorable)
Total Talent Revenue $60,253 $53,525 13% 18%
Cost of Sales 30,325 23,884 (27)% (35)%
Operating Expenses 21,400 20,993 (2)% (6)%
Amortization of Intangible Assets 3,213 2,972 (8)% (11)%
Restructuring Charges (Credits) (see Note 9) 72 (41) # #
Contribution to Profit 5,243 5,717 (8)% (7)%
Restructuring Charges (Credits) (see Note 9) 72 (41) # #
Adjusted Contribution to Profit 5,315 5,676 (6)% (5)%
Depreciation and amortization 5,458 5,605 3% (1)%
Adjusted EBITDA $10,773 $11,281 (5)% (2)%
Adjusted EBITDA Margin 17.9% 21.1%

# Not meaningful

Revenue:

Talent revenue increased $6.7 million, or 13%, as compared with the prior year on a reported basis. On a constant currency basis, revenue increased 18% as compared with the prior year. This was primarily due to double-digit growth in placements and, to a lesser extent, corporate training driving performance. For the three months ended January 31, 2023, we delivered approximately 38% growth in talent placements in talent development (Wiley Edge).

Adjusted EBITDA:

On a constant currency basis, Adjusted EBITDA decreased 2% as compared with the prior year. This was primarily due to investments to drive scale in talent development (Wiley Edge), and increased inflationary impacts on placements.

CORPORATE EXPENSES:

Corporate expenses for the three months ended January 31, 2023 decreased $5.1 million, or 10%, as compared with the prior year. On a constant currency basis, excluding restructuring charges and a legal settlement, these expenses decreased 26%. This was primarily due to lower incentive compensation accrual and, to a lesser extent, reduced technology expenses.

RESULTS OF OPERATIONS – NINE MONTHS ENDED JANUARY 31, 2023

NINE MONTHS SUMMARY:

  • US GAAP Results: Consolidated Revenue of $1,493.8 million (-3%, compared with the prior year), Operating Loss of $(26.6) million (compared with the prior year Operating Income of $160.8 million), Diluted Loss per Share of $(0.92) (compared with the prior year Diluted Earnings per Share of $1.86)
  • Adjusted Results (at constant currency compared with the prior year): Consolidated Revenue of $1,493.8 million (+1%, compared with the prior year), Adjusted EBITDA of $285.2 million (-11%, compared with the prior year), and Adjusted EPS of $2.40 (-23%, compared with the prior year)

CONSOLIDATED RESULTS OF OPERATIONS

Revenue:

Revenue for the nine months ended January 31, 2023 decreased $43.5 million, or 3%, as compared with the prior year. On a constant currency basis, revenue increased 1% as compared with the prior year including contributions from acquisitions. Excluding the contributions from acquisitions, organic revenue was flat on a constant currency basis.

See the “Segment Operating Results” below for additional details on each segment’s revenue and Adjusted EBITDA performance.

Cost of Sales:

Cost of sales for the nine months ended January 31, 2023 increased $4.7 million, or 1%, as compared with the prior year. On a constant currency basis, cost of sales increased 4% as compared with the prior year. This increase was primarily due to higher employee costs to support the growth in placements in the Talent segment, partially offset by lower royalty costs.

Operating and Administrative Expenses:

Operating and administrative expenses for the nine months ended January 31, 2023 decreased $8.7 million, or 1%, as compared with the prior year. On a constant currency basis, operating and administrative expenses increased 3% as compared with the prior year primarily reflecting higher employment costs, travel and entertainment costs and, to a lesser extent, technology costs, and a $3.7 million charge related to the settlement of a litigation matter related to consideration for a previous acquisition in the three months ended January 31, 2023.

Impairment of Goodwill:

We recorded an impairment of goodwill for the nine months ended January 31, 2023 of $99.8 million. This charge is reflected in the Impairment of goodwill in the Unaudited Condensed Consolidated Statements of Net (Loss) Income. See above and Note 12, “Goodwill and Intangible Assets” for more details on these charges.

Restructuring and Related Charges (Credits):

Fiscal Year 2023 Restructuring Program

For the nine months ended January 31, 2023, we recorded pretax restructuring charges of $44.3 million related to this program, which includes $7.5 million related to the closure of our operations in Russia as described above. These charges are reflected in Restructuring and related charges (credits) on our Unaudited Condensed Consolidated Statements of Net (Loss) Income. This restructuring charge primarily reflects the following charges:

  • Severance charges of $24.6 million for the elimination of certain positions;
  • Impairment charges of $12.7 million, which included the impairment of operating lease ROU assets of $7.6 million related to certain leases that will be subleased, and the related property and equipment of $5.1 million;
  • Acceleration of expense of $2.0 million, which included the acceleration of rent expense associated with operating lease ROU assets of $0.9 million related to certain leases that will be abandoned or terminated and the related depreciation and amortization of property and equipment of $1.1 million;
  • Ongoing facility-related costs with previously vacated properties that resulted in additional restructuring charges of $3.4 million; and
  • Consulting, relocation and other costs of $1.6 million.

See Note 9, “Restructuring and Related Charges (Credits)” for more details on these charges.

Business Optimization Program

For the nine months ended January 31, 2023 and 2022, we recorded pretax restructuring charges of $0.9 million and credits of $1.2 million, respectively, related to this program. These charges and credits are reflected in Restructuring and related charges (credits) on our Unaudited Condensed Consolidated Statements of Net (Loss) Income. See Note 9, “Restructuring and Related Charges (Credits)” for more details on these charges and credits.

For the impact of our restructuring programs on diluted (loss) earnings per share, see the section below, “Diluted (Loss) Earnings per Share (EPS).”

Amortization of Intangible Assets:

Amortization of intangible assets was $65.4 million for the nine months ended January 31, 2023, an increase of $1.7 million, or 3%, as compared with the prior year. On a constant currency basis, amortization of intangible assets increased 6% as compared with the prior year primarily due to the acceleration of expense of $4.6 million related to the discontinued use of the mthree trademark and, to a lesser extent, other acquisitions completed in fiscal year 2022 and 2023. These were partially offset by the completion of amortization of certain acquired intangible assets. See Note 3, “Acquisitions” for more details on these acquisitions.

On January 1, 2020, Wiley acquired mthree, a talent placement provider that addresses the IT skills gap by finding, training, and placing job-ready technology talent in roles with leading corporations worldwide. Its results of operations are included in our Talent segment. In late May 2022, Wiley renamed the mthree talent development solution to Wiley Edge and discontinued use of the mthree trademark during the three months ended July 31, 2022. As a result of these actions, we determined that a revision of the useful life was warranted and the intangible asset was fully amortized over its remaining useful life resulting in accelerated amortization expense of $4.6 million in the three months ended July 31, 2022.

Operating (Loss) Income, Adjusted Operating Income (OI) and Adjusted EBITDA:

Operating loss was $(26.6) million for the nine months ended January 31, 2023 compared with prior year operating income of $160.8 million. The decrease was primarily due to the impairment of goodwill in the three months ended January 31, 2023 as described above and, to a lesser extent, an increase in restructuring charges, operating and administrative expenses, and costs of sales, partially offset by an increase in revenue.

Adjusted OI on a constant currency basis and excluding restructuring charges (credits), impairment of goodwill, legal settlement, and the accelerated amortization of an intangible asset, decreased 22% as compared with the prior year primarily due to an increase in operating and administrative expenses, and cost of sales, partially offset by higher revenues as described above.

Adjusted EBITDA on a constant currency basis and excluding restructuring charges (credits), decreased 11% as compared with the prior year primarily due to a decrease in Adjusted OI.

Adjusted OI

Below is a reconciliation of our consolidated US GAAP Operating (Loss) Income to Non-GAAP Adjusted OI:

Nine Months Ended January 31, 2023 2022
US GAAP Operating (Loss) Income $(26,582) $160,845
Adjustments:
Restructuring and related charges (credits) 45,204 (1,161)
Impairment of goodwill 99,800 —
Legal settlement 3,671 —
Accelerated amortization of an intangible asset (1) 4,594 —
Non-GAAP Adjusted OI $126,687 $159,684

(1) As described above, we determined that a revision of the useful life of the mthree trademark was warranted and the intangible asset was fully amortized over its remaining useful life resulting in accelerated amortization expense of $4.6 million in the three months ended July 31, 2022.

Adjusted EBITDA

Below is a reconciliation of our consolidated US GAAP Net (Loss) Income to Non-GAAP EBITDA and Adjusted EBITDA:

Nine Months Ended January 31, 2023 2022
Net (Loss) Income $(51,111) $105,163
Interest expense 27,185 14,739
(Benefit) provision for income taxes (1,397) 52,673
Depreciation and amortization 163,142 162,484
Non-GAAP EBITDA 137,819 335,059
Impairment of goodwill 99,800 —
Legal settlement 3,671 —
Restructuring and related charges (credits) 45,204 (1,161)
Foreign exchange transaction (gains) losses (283) 1,488
Gain on sale of certain assets — (3,694)
Other income, net (976) (9,524)
Non-GAAP Adjusted EBITDA $285,235 $322,168

Interest Expense:

Interest expense was $27.2 million for the nine months ended January 31, 2023, compared with the prior year of $14.7 million. This increase was primarily due to a higher weighted average effective interest rate.

Foreign Exchange Transaction Gains (Losses):

Foreign exchange transaction gains of $0.3 million for the nine months ended January 31, 2023 were primarily due to gains on our foreign currency denominated third party accounts receivable and payable balances due to the impact of the change in average foreign exchange rates as compared to the US dollar.

Foreign exchange transaction losses of $1.5 million for the nine months ended January 31, 2022 were primarily due to losses on our foreign currency denominated third-party accounts receivable and payable balances due to the impact of the change in average foreign exchange rates as compared to the US dollar.

Gain on Sale of Certain Assets:

The gain on the sale of certain assets is due to the sale of our world languages product portfolio which was included in our Academic segment and resulted in a pretax gain of approximately $3.7 million during the nine months ended January 31, 2022.

Other Income, net

Other income, net was $1.0 million for the nine months ended January 31, 2023, a decrease of $8.5 million as compared with the prior year. This decrease was primarily due to lower pension income for our defined benefit plans in the nine months ended January 31, 2023.

(Benefit) Provision for Income Taxes:

Below is a reconciliation of our US GAAP (Loss) Income Before Taxes to Non-GAAP Adjusted Income Before Taxes:

Nine Months Ended January 31, 2023 2022
US GAAP (Loss) Income Before Taxes $(52,508) $157,836
Pretax Impact of Adjustments:
Impairment of goodwill 99,800 —
Legal settlement 3,671 —
Restructuring and related charges (credits) 45,204 (1,161)
Foreign exchange losses on intercompany transactions 906 494
Amortization of acquired intangible assets 68,611 67,081
Gain on sale of certain assets — (3,694)
Non-GAAP Adjusted Income Before Taxes $165,684 $220,556

51

Below is a reconciliation of our US GAAP Income Tax (Benefit) Provision to Non-GAAP Adjusted Income Tax Provision, including our US GAAP Effective Tax Rate and our Non-GAAP Adjusted Effective Tax Rate:

Nine Months Ended January 31, 2023 2022
US GAAP Income Tax (Benefit) Provision $(1,397) $52,673
Income Tax Impact of Adjustments (1):
Impairment of goodwill 4,857 —
Legal settlement 716 —
Restructuring and related charges (credits) 11,159 (118)
Foreign exchange losses on intercompany transactions 274 258
Amortization of acquired intangible assets 14,811 15,097
Gain on sale of certain assets — (922)
Income Tax Adjustments:
Impact of increase in UK statutory rate on deferred tax balances (2) — (20,726)
Non-GAAP Adjusted Income Tax Provision $30,420 $46,262
US GAAP Effective Tax Rate 2.7% 33.4%
Non-GAAP Adjusted Effective Tax Rate 18.4% 21.0%

(1) For the nine months ended January 31, 2023, the tax impact was $5.5 million from current taxes and $26.3 million from deferred taxes. For the nine months ended January 31, 2022, substantially all of the tax impact was from deferred taxes.

(2) These adjustments impacted deferred taxes in the nine months ended January 31, 2022.

Our effective tax rate fluctuates based on, among other factors, where income is earned and the level of income relative to tax attributes. The US GAAP effective tax rate for the nine months ended January 31, 2023 was 2.7% compared to 33.4% for the nine months ended January 31, 2022. The US GAAP effective tax rate for the nine months ended January 31, 2023 was less than the US GAAP effective tax rate for the nine months ended January 31, 2022 after taking into account certain discrete items realized related to the filing of the consolidated US federal income tax return for the year ended April 30, 2022, the tax impact on the impairment of goodwill, as well as the geographic mix of earnings, the impact of US state taxes, and a discrete item relating to restricted stock compensation.

Excluding the tax impact of the impairment of goodwill, restructuring and other adjustments noted in the table above, the Non-GAAP adjusted effective tax rate was 18.4% for the nine months ended January 31, 2023, compared to 21.0% for the nine months ended January 31, 2022. The reduction in the Non-GAAP adjusted effective tax rate for the nine months ended January 31, 2023 compared with the prior year was primarily due to the same factors described above.

Diluted (Loss) Earnings per Share (EPS):

EPS for the nine months ended January 31, 2023 was a loss of $(0.92) per share compared with earnings of $1.86 per share for the nine months ended January 31, 2022. This decrease was due to an operating loss in the nine months ended January 31, 2023 and, to a lesser extent, higher interest expense, lower pension income, and the gain on sale of certain assets in the prior year, partially offset by an income tax benefit in the nine months ended January 31, 2023.

Below is a reconciliation of our US GAAP (Loss) Earnings Per Share to Non-GAAP Adjusted EPS. The amount of the pretax, and the related income tax impact for the adjustments included in the table below, are presented in the section above, “(Benefit) Provision for Income Taxes”.

INDEX

Nine Months Ended January 31, 2023 2022
US GAAP (Loss) Earnings Per Share $(0.92) $1.86
Adjustments:
Impairment of goodwill 1.69 —
Legal settlement 0.05 —
Restructuring and related charges (credits) 0.60 (0.02)
Foreign exchange losses on intercompany transactions 0.01 —
Amortization of acquired intangible assets 0.96 0.93
Gain on sale of certain assets — (0.05)
Income tax adjustments — 0.37
EPS impact of using weighted-average dilutive shares for adjusted EPS calculation (1) 0.01 —
Non-GAAP Adjusted EPS $2.40 $3.09

(1) Represents the impact of using diluted weighted-average number of common shares outstanding (56.3 million shares for the nine months ended January 31, 2023) included in the Non-GAAP Adjusted EPS calculation in order to apply the dilutive impact on adjusted net income due to the effect of unvested restricted stock units and other stock awards. This impact occurs when a US GAAP net loss is reported and the effect of using dilutive shares is antidilutive.

On a constant currency basis, Adjusted EPS decreased 23% primarily due to a lower Adjusted OI and, to a lesser extent, an increase in interest expense, and lower pension income, partially offset by lower income tax expense.

SEGMENT OPERATING RESULTS

RESEARCH: Revenue: Nine Months Ended January 31, 2023 2022 % Change Favorable (Unfavorable) Constant Currency % Change Favorable (Unfavorable)
Research Publishing (1) $685,884 $706,690 (3)% 1%
Research Solutions (1) 113,988 106,561 7% 11%
Total Research Revenue 799,872 813,251 (2)% 2%
Cost of Sales 213,108 218,369 2% (1)%
Operating Expenses 351,016 341,084 (3)% (8)%
Amortization of Intangible Assets 35,009 35,556 2% (3)%
Restructuring Charges (see Note 9) 1,577 238 # #
Contribution to Profit 199,162 218,004 (9)% (8)%
Restructuring Charges (see Note 9) 1,577 238 # #
Adjusted Contribution to Profit 200,739 218,242 (8)% (7)%
Depreciation and amortization 70,308 71,140 1% (2)%
Adjusted EBITDA $271,047 $289,382 (6)% (5)%
Adjusted EBITDA Margin 33.9% 35.6%

# Not meaningful

(1) As previously announced in May 2022, our revenue by product type previously referred to as Research Platforms was changed to Research Solutions. Research Solutions includes infrastructure and publishing services that help societies and corporations thrive in a complex knowledge ecosystem. In addition to Platforms (Atypon), certain product offerings such as corporate sales which included the recent acquisitions of Madgex Holdings Limited (Madgex), and Bio-Rad Laboratories Inc.’s Informatics products (Informatics) that were previously included in Research Publishing moved to Research Solutions to align with our strategic focus. Research Solutions also includes product offerings related to certain recent acquisitions such as J&J, and EJP. Prior period results have been revised to the new presentation. There were no changes to the total Research segment or our consolidated financial results. The revenue reclassified was $68.4 million for the nine months ended January 31, 2022, $93.3 million for the year ended April 30, 2022, and $80.3 million for the year ended April 30, 2021.

Revenue:

Research revenue for the nine months ended January 31, 2023 decreased $13.4 million, or 2%, as compared with the prior year on a reported basis. On a constant currency basis, revenue increased 2% as compared with the prior year. Excluding revenue from acquisitions, organic revenue increased 1% on a constant currency basis. This increase was primarily due to an increase in open access publishing, partially offset by subscriptions. As described above in the three months ended January 31, 2023, open access was impacted by the publishing pause in a Hindawi special issues program. Open access article output growth was approximately 11% for the nine months ended January 31, 2023, as compared with the prior year.

Adjusted EBITDA:

On a constant currency basis, Adjusted EBITDA decreased 5% as compared with the prior year. This decrease was primarily due to investments to optimize and scale publishing and solutions and, to a lesser extent, higher employment costs, and travel and entertainment costs due to the resumption of in-person activities, which more than offset the increase in revenue.

ACADEMIC: Revenue: Nine Months Ended January 31, 2023 2022 % Change Favorable (Unfavorable) Constant Currency % Change Favorable (Unfavorable)
Academic Publishing $354,728 $400,740 (11)% (9)%
University Services 152,892 169,002 (10)% (9)%
Total Academic Revenue 507,620 569,742 (11)% (9)%
Cost of Sales 215,344 230,985 7% 5%
Operating Expenses 243,084 250,798 3% —%
Impairment of Goodwill (see Note 12) 99,800 — # #
Amortization of Intangible Assets 17,700 19,131 7% 7%
Restructuring Charges (Credits) (see Note 9) 10,091 (347) # #
Contribution to Profit (78,399) 69,175 # #
Restructuring Charges (Credits) (see Note 9) 10,091 (347) # #
Impairment of Goodwill (see Note 12) 99,800 — # #
Adjusted Contribution to Profit 31,492 68,828 (54)% (52)%
Depreciation and amortization 61,547 61,622 —% (1)%
Adjusted EBITDA $93,039 $130,450 (29)% (27)%
Adjusted EBITDA Margin 18.3% 22.9%

# Not meaningful

Revenue:

Academic revenue decreased $62.1 million, or 11%, as compared with the prior year on a reported basis. On a constant currency basis, revenue decreased 9% as compared with the prior year. Excluding revenue from acquisitions, organic revenue decreased 10% on a constant currency basis. This decrease was primarily due a decrease in Academic Publishing due to a decline in print and digital, partially offset by an increase in courseware. University Services revenue decreased primarily due to continued online enrollment challenges and lower fee for service revenue.

Adjusted EBITDA:

On a constant currency basis, Adjusted EBITDA decreased 27% as compared with the prior year. This decrease was primarily due to lower revenues and, to a lesser extent, inflationary impacts on inventory, higher technology and distribution costs, partially offset by expense savings, and lower annual incentive compensation.

INDEX

TALENT: Nine Months Ended January 31, 2023 2022 % Change Favorable (Unfavorable) Constant Currency % Change Favorable (Unfavorable)
Total Talent Revenue $186,281 $154,282 21% 28%
Cost of Sales 89,932 64,300 (40)% (51)%
Operating Expenses 63,502 64,371 1% (5)%
Amortization of Intangible Assets 12,559 8,996 (40)% (43)%
Restructuring Charges (see Note 9) 2,400 245 # #
Contribution to Profit 17,888 16,370 9% 13%
Restructuring Charges (see Note 9) 2,400 245 # #
Accelerated amortization of an intangible asset (1) 4,594 — # #
Adjusted Contribution to Profit 24,882 16,615 50% 53%
Depreciation and amortization 14,688 17,304 15% 9%
Adjusted EBITDA $39,570 $33,919 17% 21%
Adjusted EBITDA Margin 21.2% 22.0%

# Not meaningful

(1) On January 1, 2020, Wiley acquired mthree, a talent placement provider that addresses the IT skills gap by finding, training, and placing job-ready technology talent in roles with leading corporations worldwide. Its results of operations are included in our Talent segment. In late May 2022, Wiley renamed the mthree talent development solution to Wiley Edge and discontinued use of the mthree trademark during the three months ended July 31, 2022. As a result of these actions, we determined that a revision of the useful life was warranted, and the intangible asset was fully amortized over its remaining useful life resulting in accelerated amortization expense of $4.6 million in the three months ended July 31, 2022.

Revenue:

Talent revenue increased $32.0 million, or 21%, as compared with the prior year on a reported basis. On a constant currency basis, revenue increased 28% as compared with the prior year. This was primarily due to double-digit growth in placements and, to a lesser extent, an increase in corporate training. For the nine months ended January 31, 2023, we delivered approximately 38% growth in talent placements in talent development (Wiley Edge).

Adjusted EBITDA:

On a constant currency basis, Adjusted EBITDA increased 21% as compared with the prior year. This was primarily due to revenue, partially offset by increased inflationary impacts on placements and, to drive scale in talent development (Wiley Edge)

CORPORATE EXPENSES:

Corporate expenses for the nine months ended January 31, 2023 increased $22.5 million, or 16%, as compared with the prior year. On a constant currency basis and excluding restructuring (credits) charges and a legal settlement, these expenses decreased 5% as compared with the prior year. This was primarily due to lower employee related costs, including lower annual incentive compensation for fiscal year 2023.

FISCAL YEAR 2023 OUTLOOK:

Wiley is reducing its financial outlook at constant currency:

  • Revenue: downward revision by an additional $45 million to $60 million primarily due to increased Academic market headwinds and the publishing pause in Hindawi special issues which is projected to impact revenue up to $30 million and Adjusted EBITDA up to $25 million.
  • Adjusted EBITDA: downward revision by $30 million to $40 million due to lower projected revenue.
  • Adjusted EPS: downward revision by 40 cents to 50 cents due to lower projected Adjusted EBITDA and higher interest expense.
  • Free Cash Flow: downward revision primarily due to lower projected cash earnings and higher restructuring payments, mainly related to the closing of Wiley's Russia tech development center. Our capital expenditure range remains at $110 million to $120 million.

Amounts in millions, except Adjusted EPS

Metric Fiscal Year 2022 Actual (1) Fiscal Year 2023 Outlook Constant currency Previous (1) Fiscal Year 2023 Outlook Constant currency Current (1) Foreign Currency Impact (2) Fiscal Year 2023 Outlook Year to date average rates Current (3)
Revenue $2,083 $2,110 - $2,150 $2,065 - $2,090 $(60) $2,005 - $2,030
Adjusted EBITDA $433 $425 - $450 $395 - $410 Immaterial $395 - $410
Adjusted EPS $4.16 $3.70 - $4.05 $3.30 - $3.55 Immaterial $3.30 - $3.55
Free Cash Flow $223 $210 - $235 $160 - $185 Immaterial $160 - $185

(1) Based on fiscal year 2022 average rates of 1.15 euro and 1.36 British pound.

(2) Variance between fiscal year 2022 average rates and year to date fiscal year 2023 average rates.

(3) Fiscal year 2023 outlook at average year to date rates of 1.04 euro and 1.20 British pound.

In August 2022, the White House Office of Science and Technology Policy (OSTP) issued guidance for US federal agencies to make federally funded research freely available starting no later than December 31, 2025, without an embargo. For reference, approximately 11% of Wiley’s published articles today are funded by US federal departments impacted by this guidance, and a third of those articles are already open access. Wiley has been working for several years with the OSTP and other stakeholders around the world to support the orderly transition to open research. This new guidance is aligned with Wiley’s stated strategy and mission, and is supported by the growth the Company is seeing in open research publishing. Wiley supports multiple publishing models to execute against the industry’s shared objective of unlocking access to scientific research and improving the efficiency of peer review and publication. Those models include journal subscriptions (“pay to read”), transformational agreements (“pay to read and publish”) and open access (“pay to publish”). In the past three years, our open access revenues, including from transformational agreements, have increased from less than 6% of total Research Publishing revenues to approximately 32% today. Based on our assessment of the guidance, we do not believe it will have a material financial impact on our Company.

LIQUIDITY AND CAPITAL RESOURCES

Principal Sources of Liquidity

We believe that our operating cash flow, together with our revolving credit facilities and other available debt financing, will be adequate to meet our operating, investing and financing needs in the foreseeable future. There can be no assurance that continued or increased volatility in the global capital and credit markets will not impair our ability to access these markets on terms commercially acceptable in the future. We do not have any off-balance-sheet debt. We will continue to pursue attractive opportunities to add scale and provide enhanced technology-enabled services in research and online education.

As of January 31, 2023, we had cash and cash equivalents of $126.4 million, of which approximately $119.8 million, or 95%, was located outside the US. Maintenance of these cash and cash equivalent balances outside the US does not have a material impact on the liquidity or capital resources of our operations. Nonetheless, we intend to repatriate earnings from our non-US subsidiaries, and as we repatriate these funds to the US, we will be required to pay income taxes in various US state and local jurisdictions, and applicable withholding or similar taxes in the periods in which such repatriation occurs. Accordingly, as of January 31, 2023, we have an approximately $2.7 million liability related to the estimated taxes that would be incurred upon repatriating certain non-US earnings.

On November 30, 2022, we entered into the second amendment to the Third Amended and Restated Credit Agreement (collectively, the Amended and Restated CA). The Amended and Restated CA as of November 30, 2022 provided for senior unsecured credit facilities comprised of a (i) five-year revolving credit facility in an aggregate principal amount up to $1.115 billion, (ii) a five-year term loan A facility consisting of $200 million, and (iii) $185 million aggregate principal amount revolving credit facility through May 2024. See Note 15, “Debt and Available Credit Facilities” for further details on the Amended and Restated CA.

As of January 31, 2023, we had approximately $945.6 million of debt outstanding, net of unamortized issuance costs of $0.8 million, and approximately $553.4 million of unused borrowing capacity under our Amended and Restated CA and other facilities. The Amended and Restated CA contains certain customary affirmative and negative covenants, including a financial covenant in the form of a consolidated net leverage ratio and consolidated interest coverage ratio, which we were in compliance with as of January 31, 2023.

Analysis of Historical Cash Flows

The following table shows the changes in our Unaudited Condensed Consolidated Statements of Cash Flows for the nine months ended January 31, 2023 and 2022.

Nine Months Ended January 31, 2023 2022
Net cash provided by operating activities $53,718 $158,484
Net cash used in investing activities (80,072) (152,051)
Net cash provided by financing activities 55,284 13,099
Effect of foreign currency exchange rate changes on cash, cash equivalents and restricted cash $(2,670) $(3,875)

Cash flow from operations is seasonally a use of cash in the first half of Wiley’s fiscal year principally due to the timing of collections for annual journal subscriptions, which typically occurs in the beginning of the second half of our fiscal year.

Free cash flow less product development spending helps assess our ability, over the long term, to create value for our shareholders, as it represents cash available to repay debt, pay common dividends, and fund share repurchases, and acquisitions. Below are the details of Free cash flow less product development spending.

Free Cash Flow less Product Development Spending:

Nine Months Ended January 31, 2023 2022
Net cash provided by operating activities $53,718 $158,484
Less: Additions to technology, property and equipment (57,616) (60,668)
Less: Product development spending (17,763) (20,388)
Free cash flow less product development spending $(21,661) $77,428

Net Cash Provided by Operating Activities

The following is a summary of the $104.8 million change in Net cash provided by operating activities for the nine months ended January 31, 2023 compared with the nine months ended January 31, 2022 (amounts in millions).

Net cash provided by operating activities – Nine months ended January 31, 2022 $158.5
Net (loss) income adjusted for items to reconcile net (loss) income to net cash provided by operating activities, which would include such noncash items as, depreciation and amortization, and the change in deferred taxes (53.5)
Working capital changes:
Accounts receivable, net and contract liabilities 19.4
Accounts payable and accrued royalties (27.9)
Changes in other assets and liabilities (42.8)
Net cash provided by operating activities – Nine months ended January 31, 2023 $53.7

The favorable change in accounts receivable, net and contract liabilities was primarily due to the timing of collections with customers.

The unfavorable change in accounts payable and accrued royalties was primarily due to the timing of payments.

The unfavorable changes in other assets and liabilities noted in the table above was primarily due to higher restructuring payments in fiscal year 2023, lower employee related costs due to lower annual incentive compensation for fiscal year 2023, and the timing of prepayments and other receivables.

Wiley expects working capital timing to largely resolve in the fourth quarter of fiscal year 2023.

Our negative working capital (current assets less current liabilities) was $229.8 million and $418.6 million as of January 31, 2023 and April 30, 2022, respectively. This $188.8 million change in negative working capital was primarily due to the seasonality of our business. The primary driver of the negative working capital is the benefit realized from unearned contract liabilities related to subscriptions for which cash has been collected in advance. The contract liabilities will be recognized as income when the products are shipped or made available online to the customers over the term of the subscription. Current liabilities as of January 31, 2023 and as of April 30, 2022 includes $369.3 million and $538.1 million, respectively, primarily related to deferred subscription revenue for which cash was collected in advance.

Cash collected in advance for subscriptions is used by us for a number of purposes, including funding operations, capital expenditures, acquisitions, debt repayments, dividend payments, and share repurchases.

Net Cash Used In Investing Activities

Net cash used in investing activities for the nine months ended January 31, 2023 was $80.1 million compared to $152.1 million in the prior year. The decrease in cash used in investing activities was primarily due to a decrease of $64.8 million in cash used to acquire businesses.

Net Cash Provided By Financing Activities

Net cash provided by financing activities was $55.3 million for the nine months ended January 31, 2023 compared to $13.1 million for the nine months ended January 31, 2022. This increase in cash provided by financing activities was primarily due to an increase in net borrowings of long-term debt of $57.0 million, partially offset by a change in book overdrafts of $11.0 million.

In the nine months ended January 31, 2023, we increased our quarterly dividend to shareholders to $1.39 per share annualized versus $1.38 per share annualized in the prior year.

The following table summarizes the shares repurchased of Class A and Class B Common Stock for the nine months ended January 31, 2023 and 2022 (shares in thousands):

Nine Months Ended January 31, 2022 2021
Shares repurchased – Class A 539 446
Shares repurchased – Class B 1 2
Average price – Class A and Class B $44.47 $55.48

60

Market risk

As filed, 6,054 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

We are exposed to market risk primarily related to interest rates, foreign exchange, and credit risk. It is our policy to monitor these exposures and to use derivative financial investments and/or insurance contracts from time to time to reduce fluctuations in earnings and cash flows when it is deemed appropriate to do so. We do not use derivative financial instruments for trading or speculative purposes.

Interest Rates

From time to time, we may use interest rate swaps, collars, or options to manage our exposure to fluctuations in interest rates. It is management’s intention that the notional amount of interest rate swaps be less than the variable rate loans outstanding during the life of the derivatives.

The information set forth in Note 16, “Derivatives Instruments and Hedging Activities,” of the Notes to Unaudited Condensed Consolidated Financial Statements under the caption “Interest Rate Contracts,” is incorporated herein by reference.

On an annual basis, a hypothetical one percent change in interest rates for the $495.6 million of unhedged variable rate debt as of January 31, 2023 would affect net income and cash flow by approximately $4.0 million.

Foreign Exchange Rates

Fluctuations in the currencies of countries where we operate outside the US may have a significant impact on financial results. We are primarily exposed to movements in British pound sterling, euros, Canadian and Australian dollars, and certain currencies in Asia. The statements of financial position of non-US business units are translated into US dollars using period-end exchange rates for assets and liabilities and the statements of income are translated into US dollars using weighted-average exchange rates for revenues and expenses.

Our significant investments in non-US businesses are exposed to foreign currency risk. Adjustments resulting from translating assets and liabilities are reported as a separate component of Accumulated other comprehensive loss, net of tax within Shareholders’ Equity under the caption Foreign currency translation adjustment. During the three months ended January 31, 2023, we recorded foreign currency translation gains in Accumulated other comprehensive loss, net of tax of approximately $50.3 million, primarily as a result of the fluctuations of the US dollar relative to the British pound sterling and, to a lesser extent, the euro. During the nine months ended January 31, 2023, we recorded foreign currency translation (losses) in Accumulated other comprehensive loss, net of tax of approximately $(5.6) million, primarily as a result of the fluctuations of the US dollar relative to the British pound sterling, partially offset by fluctuations of the US dollar relative to the euro. During the three and nine months ended January 31, 2022, we recorded foreign currency translation losses in Accumulated other comprehensive loss, net of tax of approximately $(15.9) million and $(31.3) million, respectively, primarily as a result of the fluctuations of the US dollar relative to the euro and the British pound sterling.

Exchange rate gains or losses related to foreign currency transactions are recognized as transaction gains or losses on the Unaudited Condensed Consolidated Statements of Net (Loss) Income as incurred. Under certain circumstances, we may enter into derivative financial instruments in the form of foreign currency forward contracts to hedge against specific transactions, including intercompany purchases and loans.

The information set forth in Note 16, “Derivatives Instruments and Hedging Activities,” of the Notes to Unaudited Condensed Consolidated Financial Statements under the caption “Foreign Currency Contracts,” is incorporated herein by reference.

Sales Return Reserves

The estimated allowance for print book sales returns is based upon historical return patterns, as well as current market trends in the businesses in which we operate. In connection with the estimated sales return reserves, we also include a related increase to inventory and a reduction to accrued royalties as a result of the expected returns.

The reserves are reflected in the following accounts of our Unaudited Condensed Consolidated Statements of Financial Position:

January 31, 2023 April 30, 2022
Increase in Inventories, net $7,378 $7,820
Decrease in Accrued royalties $(3,678) $(3,893)
Increase in Contract liabilities $27,974 $31,135
Print book sales return reserve net liability balance $(16,918) $(19,422)

A one percent change in the estimated sales return rate could affect net income by approximately $0.4 million. A change in the pattern or trends in returns could affect the estimated allowance.

Customer Credit Risk

In the journal publishing business, subscriptions are primarily sourced through journal subscription agents who, acting as agents for library customers, facilitate ordering by consolidating the subscription orders/billings of each subscriber with various publishers. Cash is generally collected in advance from subscribers by the subscription agents and is principally remitted to us between the months of December and April. Although currently we have minimal credit risk exposure to these agents, future calendar-year subscription receipts from these agents are highly dependent on their financial condition and liquidity. Subscription agents account for approximately 20% of total annual consolidated revenue, and no one affiliated group of subscription agents accounts for more than 10% of total annual consolidated revenue.

Our book business is not dependent upon a single customer; however, the industry is concentrated in national, regional, and online bookstore chains. No single book customer accounts for more than 7% of total consolidated revenue and more than 14% of accounts receivable at January 31, 2023. The top 10 book customers account for approximately 11% of total consolidated revenue and approximately 24% of accounts receivable at January 31, 2023.

Controls and procedures

As filed, 1,355 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The Company’s Chief Executive Officer and Chief Financial Officer, together with the Chief Accounting Officer and other members of the Company’s management, have conducted an evaluation of the Company’s disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”) as of the end of the period covered by this report. Based on this evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that the Company's disclosure controls and procedures were effective to ensure that information required to be disclosed by the Company in reports filed or submitted under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified by the Securities and Exchange Commission's rules and forms and (ii) accumulated and communicated to the Company’s management, including its Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) during the quarter ended January 31, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Risk factors

As filed, 294 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

See Part I, Item 1A, “Risk Factors,” of our Annual Report on Form 10-K for the fiscal year ended April 30, 2022. Except as required by the federal securities law, we undertake no obligation to update or revise any risk factor, whether as a result of new information, future events or otherwise.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2023-01-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2022-11-01 to 2023-01-31$491.4mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue9 months2022-05-01 to 2023-01-31$1.49bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2022-11-01 to 2023-01-31$174.1mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue9 months2022-05-01 to 2023-01-31$518.4mus-gaap:CostOfGoodsAndServicesSold
Selling, general and administrative3 months2022-11-01 to 2023-01-31$255.8mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2022-05-01 to 2023-01-31$791.6mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2022-11-01 to 2023-01-31−$67.1mus-gaap:OperatingIncomeLoss
Operating income9 months2022-05-01 to 2023-01-31−$26.6mus-gaap:OperatingIncomeLoss
Interest expense3 months2022-11-01 to 2023-01-31$11.5mus-gaap:InterestExpense
Interest expense9 months2022-05-01 to 2023-01-31$27.2mus-gaap:InterestExpense
Income tax3 months2022-11-01 to 2023-01-31−$6.0mus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2022-05-01 to 2023-01-31−$1.4mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2022-11-01 to 2023-01-31−$71.5mus-gaap:NetIncomeLoss
Net income9 months2022-05-01 to 2023-01-31−$51.1mus-gaap:NetIncomeLoss
Diluted EPS3 months2022-11-01 to 2023-01-31−$1.29us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2022-05-01 to 2023-01-31−$0.92us-gaap:EarningsPerShareDiluted
Basic EPS3 months2022-11-01 to 2023-01-31−$1.29us-gaap:EarningsPerShareBasic
Basic EPS9 months2022-05-01 to 2023-01-31−$0.92us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2022-11-01 to 2023-01-3155,514,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2022-05-01 to 2023-01-3155,625,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2022-05-01 to 2023-01-31$53.7mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2022-05-01 to 2023-01-31$57.6mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid9 months2022-05-01 to 2023-01-31$58.1mus-gaap:PaymentsOfDividendsCommonStock
Share repurchases9 months2022-05-01 to 2023-01-31$24.0mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2023-01-31$126.4mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2023-01-31$531.2mus-gaap:AssetsCurrent
Total assetsAt period end2023-01-31$3.15bnus-gaap:Assets
Current liabilitiesAt period end2023-01-31$761.0mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2023-01-31$2.12bnus-gaap:Liabilities
Long-term debtAt period end2023-01-31$940.6mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2023-01-31$5.0mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2023-01-31$1.03bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0000107140-23-000034. Last ingested by Listed: Nov 10, 2026, 22:22 ET. Listed shows no prices and gives no investment advice.